Full-Time
Posted on 3/12/2025
£26.5kAnnually
Entry, Junior
London, UK
Company Size
10,001+
Company Stage
Acquired
Total Funding
$217.8M
Headquarters
London, United Kingdom
Founded
1974
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Paid Vacation
Life Insurance
401(k) Retirement Plan
Performance Bonus
Gym Membership
Hybrid Work Options
Dr Jose-Carlos Gutiérrez- Ramos is the Chief Science Officer at Danaher Corporation. He has held senior drug discovery roles at Pfizer, Abbvie, and GSK. As CEO and President of Synlogic, he led the company from early drug discovery to clinical stage and public marketsHe brings a wealth of experience across biotechs and pharmaceutical companies, combined with deep expertise in science and tech for successful drug discovery, drug development programmes, and marketed drugsThe appointment strengthens the company's commercial capabilities, life sciences innovation, and R&D offering, to advance Genomics' mission of changing the future of healthcareOXFORD, England, Jan. 9, 2025 /PRNewswire/ -- Genomics , a healthcare company using large-scale genetic information to develop innovative precision healthcare tools and to bring new understanding to drug discovery, today announced the appointment of Dr Jose-Carlos Gutiérrez-Ramos to its Board. The appointment will support the company's rapid growth and strengthen its commercial offering globally, with a focus on scaling its life sciences business. The announcement coincides with significant Genomics presence at the J.P
Bupa Health Services has acquired The Dermatology Partnership (TDP) from August Equity to enhance its direct-to-consumer offerings. The financial details of the deal were not disclosed. This acquisition aims to reduce long waiting times for dermatology services in the UK, benefiting Bupa's UK Insurance customers.
Bupa has launched a two-year pilot program called "My Genomic Health," establishing itself as the first major private healthcare provider in the UK to offer whole genome sequencing to selected customers.
Bupa launches gene-mapping programme to tackle common disorders with tailored 'health plans'
Bupa has appointed Kate Williams as acting managing director of health insurance for Australia.